Skip to main content

DUBLIN, February 1, 2022 /PRNewswire/ — The “Cell and Gene Therapy Market – Global Outlook and Forecast 2022-2027” report has been added to from offer.

The cell and gene therapy market size has been valued at $4.99 billion in 2021 and is expected to reach $36.92 billion by 2027, growing at a CAGR of 39.62% over the forecast period

In the field of cell and gene therapy, gene therapy has accelerated over the past 2 decades due to the discovery of several genes responsible for mutations in various diseases. Advances in the field of cell and gene therapy and innovative technologies are opening a new era for biological therapeutics. Additionally, the PRIME designation and product marketing clearance provides a new opportunity for manufacturer funding and revenue generation.


According to the American Society of Cell + Gene Therapy report in 2021, increasing number of cell and gene therapy products, application rate, and products in clinical trials are driving the growth of the market.

According to the 2021 Dive Biopharma Report, biotech companies that have actively engaged in regenerative drugs and therapies reported $14 billion funding only in six months of 2021, which would have been $19.9 billion for the whole year.


The increasing application of gene therapies in disease diagnosis and the rapid growth of new drug applications will open a new market space in the coming years. In 2020, approximately $2.3 billion funding has only been reported by private companies for gene therapies. By 2025, the FDA is expected to approve 10-20 products every year, driving the global cell and gene therapy manufacturing market.

In 2020, Medicine in Development Report 2020, approximately 176 products were reported in cancer therapies in development procedures.


North America: High economic status and high expenditure on healthcare services is driving the cell and gene therapy market in North America. National institutes of health, industries, academic institutes and hospitals are major contributors to the sponsorship and funding of cell and gene therapy products.

Europe: Rising Funding for Cell and Gene Therapy Drives Steady Growth of Cell and Gene Therapy Market in Europe. About $2.6 billion funding was declared in Europe for CGTs in 2020, which increased by 103% compared to previous years. In the cell therapy segment, $1.8 billion and in gene therapy, $2.3 billion funding recognized in 2020, which increased by 196% and 111% growth respectively


Key players in the cell and gene therapy market are Gilead Sciences, Novartis, Smith Nephew, Amgen, Organogenesis, Roche (Spark Therapeutics), Dendreon, Vericel, and Bristol-Myers Squibb Company.

An increasing number of mergers and acquisitions gives new growth potential to the market. Gilead Sciences acquired Kite Pharma in 2020. Additionally, Novartis acquired Avexis in 2018 and Smith & Nephew acquired Osiris Therapeutics.


  • Merger & Acquisition
  • Expansion of manufacturing plants and technological advancement
  • Extension of applications for cell and gene therapies
  • Growing demand for CAR T cell therapies
  • New product approvals and increase in pipeline products


  • Sciences of Gilead
  • Novartis
  • Nephew Smith (Osiris Therapeutic)
  • Amgen
  • Organogenesis
  • Roche (Spark Therapeutics)
  • Dendreon
  • Vericel
  • Bristol-Myers Squibb


  • Abeona Therapeutic
  • APAC Biotech Pvt Ltd
  • Alnylam
  • Allovir
  • Science Tego
  • Avita Medical
  • anterogenic
  • AnGès inc.
  • BioSolution Co. Ltd.
  • Cheisi Farmaceutic
  • CollFactory
  • CO.DON
  • corestem
  • Bluebird Bio Inc.
  • bio-solution
  • Stempeutic Research
  • GC cell
  • Sanofi
  • Gensight Organic Products
  • Human Stem Cell Institute
  • JW CreaGene Co. Ltd
  • JCR Pharmaceuticals
  • Japan Tissue Engineering (J-TEC)
  • Kolon TissueGene
  • Medipost
  • MolMed
  • Nuvasive Inc.
  • Nipro Corporation
  • Orchard therapy
  • Orthocell
  • Pfizer
  • Pharmacell
  • Sibiono Genetech
  • Shanghai Sunway Biotech
  • RMS Regenerative Medical System
  • Takeda Pharmaceutical Company
  • Terumo


  • Biomarin Pharmaceutical
  • Pharmaceutical Bellicum
  • Castle Creek Biosciences Inc.
  • Libella Therapeutic Gene
  • CARsgen Therapeutic
  • Hrain Biotechnology Co. Ltd
  • Helixsmith
  • Crystal Biotech Inc.
  • JW Therapeutic
  • Therapeutic Poseida

Main topics covered:

1 Research methodology

2 research objectives

3 Research process

4 Scope and coverage

4.1 Market definition

4.2 Reference year

4.3 Scope of the study

5 Report assumptions and caveats

5.1 Main caveats

5.2 Currency conversion

5.3 Market Derivation

6 The market at a glance

7 Presentation

7.1 Overview

7.1.1 Cell and Gene Therapy Approved Products 2020-2021

7.2 Phase III Cell and Gene Therapy Products

7.3 Cell and gene therapy roadmap

8 Market Opportunities and Trends

8.1 Growing number of mergers and acquisitions

8.2 Expansion of CGT manufacturing plants

8.3 Extension of Applications for Cell and Gene Therapies

8.4 Growing Demand for Automotive T Cell Therapies

9 Market Growth Catalysts

9.1 New Product Approvals and Growing Product Pipeline

9.2 Primary designation and financial support for CGT

9.3 Growing Use of CGT Products for Treatment of Diseases

9.4 Increase in the use of CGT products for the treatment of diseases

10 Market Restrictions

10.1 High cost of cell and gene therapies

10.2 Ethical issues regarding germplasm

10.3 Strict regulations for CGT approvals

11 Market landscape

11.1 Market Overview

11.2 Market Size and Forecast

11.3 Five forces analysis

12 Therapy

12.1 Market Overview and Growth Driver

12.2 Market Overview

12.3 Gene therapy

12.4 Cell therapy

13 Application

13.1 Market Overview and Growth Driver

13.2 Market Overview

13.3 Oncology

13.4 Genetic Disorders

13.5 Dermatology

13.6 Musculoskeletal diseases

13.7 Other diseases

14 End user

14.1 Market Overview and Growth Driver

14.2 Market Overview

14.3 Hospitals

14.4 Cancer Care Centers

14.5 Wound Care Centers

14.6 Other end users

15 Geography

15.1 Market Overview and Growth Driver

15.2 Geographic overview

15.2.1 Global Cell and Gene Therapy Market by Geography

For more information about this report visit

Media Contact:

Research and Markets

Laura Wood, senior

[email protected]

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904

Fax (outside the US): +353-1-481-1716

View original content:–gene-therapy-market-research-report-2022-expanding-application-for-cell–gene-therapies– growing -request-for-self-t-cell-therapies-301472735.html

SOURCE Research and Markets